Schoenherr has advised the shareholders of Nortec Pharma on the sale of a majority stake to Frewitt.
The parties have not disclosed any financial details.
Nortec Pharma, headquartered in Poland, specializes in pharmaceutical processing solutions.
Frewitt is a Swiss-based company operating in milling and processing technologies for the pharmaceutical industry. According to Schoenherr, this transaction expands Frewitt’s product range and service offering, reinforcing its market position, while marking a strategic move for both companies to enhance their innovative capabilities and market reach.
The Schoenherr team included Partners Tomasz Kwasniewski and Szymon Okon, Counsel Dawid Brudzisz, and Associate Witold Oszczanowski.
Schoenherr did not respond to our inquiry on the matter.
